dr. Avinindita Nura Lestari from GENEPICA team contributed to the development of NeuroPrecise, a pharmacogenomics programme at RSPON Prof. Dr. dr. Mahar Mardjono Jakarta (Indonesia’s National Brain Center) designed to support more personalised approaches to neurological treatment. GENEPICA’s expertise contributed to key stages of the programme’s development, including study design and the establishment of a genomic database to support interpretation and future clinical applications. The initiative demonstrates how locally developed genomic evidence and analytical infrastructure can help translate pharmacogenomics into clinical practice and support the advancement of precision medicine in Indonesia.